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Abstract  
 
Maternal obesity is linked with adverse outcomes for mothers and babies. To get an 
overview of risk related to obesity in pregnant women, a systematic review of 
reviews was conducted. For inclusion, reviews had to compare pregnant women of 
healthy weight with women with obesity, and measure a health outcome for mother 
and/or baby. Authors conducted full-text screening, quality assurance using the 
AMSTAR tool, and data extraction steps in pairs. Narrative analysis of the 22 
reviews included showed gestational diabetes, pre-eclampsia, gestational 
hypertension, depression, instrumental and caesarean birth, and surgical site 
infection to be more likely to occur in pregnant women with obesity compared to 
women with a healthy weight. Maternal obesity is also linked to greater risk of pre-
term birth, large-for-gestational-age babies, fetal defects, congenital anomalies, and 
perinatal death. Furthermore breastfeeding initiation rates are lower and there is 
greater risk of early breastfeeding cessation in women with obesity compared with 
healthy weight women. These adverse outcomes may result in longer duration of 
hospital stay, with concomitant resource implications. It is crucial to reduce the 
burden of adverse maternal and fetal/child outcomes caused by maternal obesity. 
Women with obesity need support to lose weight before they conceive, and to 
minimise their weight gain in pregnancy.    
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Introduction   
 
Maternal obesity is becoming an increasing public health issue, and it is known that 
nutrition and metabolism play a crucial role in the health and wellbeing of both 
mother and fetus (1). Maternal obesity is reaching epidemic proportions, particularly 
in the United States (US), where prevalence of obesity in women aged 20-39 years 
increased from 28.4% in 1999 to 34% in 2008 (2, 3) but has now fallen slightly to 
31.9% (4). Across Europe, similar increases from lower starting levels are seen. The 
latest European Perinatal Health Report showed that the lowest levels of overweight 
or obesity in pregnant women were in Poland (25.6%), France (27.2%), and Slovenia 
(27.8%). The majority of other European countries had rates of 30-37%, and 
Scotland had a prevalence of 48.4%, with 20.7% of all pregnant women in the range 
of obesity (5).   
 
Maternal obesity is linked with increased rates of caesarean section, depression and 
medical complications (6). Babies of women with obesity also suffer from pre-term 
birth, still-birth and fetal anomalies (7). Maternal obesity is the most significant factor 
leading to obesity in offspring (8) and, coupled with excess weight gain in pregnancy, 
also results in long-term obesity for women (9). 
 
Several systematic reviews have been conducted in an attempt to synthesise an 
overall conclusion as to which outcomes can, with certainty, be linked with obesity in 
pregnancy. These reviews are of differing scope and quality and may, also, have 
opposing results, leading to confusion among clinicians as to what are the true risks 
related to maternal obesity. In addition, clinicians (and researchers) may read only 
one of a number of reviews and base clinical decisions or suggestions for changed 
practice on this, or ignore the evidence if the review is small, or does not cover their 
country. The benefit of bringing together a number of systematic reviews on a 
particular outcome is that the reader is more likely to be convinced by the weight of 
evidence. Conducting an overview that includes all reviews relating to a topic also 
ensures that the full range of adverse outcomes for that health issue can be seen in 
one paper. 
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Accordingly, our research group set out to conduct a systematic review of systematic 
reviews, as promoted by the Cochrane Collaboration (10) and described by other 
papers (11, 12). The aim was to summarise the findings of published systematic 
reviews regarding the possible risks for pregnant women with obesity, and their 
infants, compared to pregnant women with a healthy weight and their infants.  
 
Methods 
 
Search strategy 
 
The accepted definitions of obesity (greater than or equal to Body Mass Index (BMI) 
30 kg/m2), severe obesity (BMI ≥ 35 kg/m2), and healthy weight between 18.5 and 
24.9 kg/m2 (13) were planned for use. A protocol was developed a priori, outlining 
the review aim and procedure.  An inclusion/exclusion criteria list (based on the 
PICOS framework in Box 1) was created to identify all the pertinent systematic 
reviews. This step was done by two reviewers, with additions from the rest of team, 
and then tested. A comprehensive and systematic search was done in the following 
databases: PubMed, CINAHL, Cochrane and Scopus, from inception until May 2014, 
to identify systematic reviews only. The PICOS framework used (population, 
intervention, comparison, outcomes, study designs) and resulting search string are 
shown in Box 1. 
 
Box 1: Search string used (for MeSH terms and key words in abstract and title) 
 
PICOS framework and search string 
Population: All pregnant women 
Intervention: Obesity – as defined by the authors, BMI usually measured before 
pregnancy or at booking 
Comparison: Healthy weight, as defined by the authors  
Outcome: Infant or maternal health outcome 
Study design: Systematic review or meta-analysis of cohort studies; systematic 
reviews of intervention/experimental studies if the control groups provided outcomes 
due to obesity 
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Search string: (Pregnancy OR "Postpartum Period" OR pregnant OR "post partum" 
OR postpartum OR "post natal" OR postnatal OR puerperium OR antenatal OR 
prenatal OR gestation OR gestational OR gravida OR perinatal) AND (Obese OR 
obesity) AND (“Systematic review” OR “meta-analysis”) 
 
Our search was restricted to peer-reviewed articles and we included mainly 
systematic reviews of cohort studies or case studies, where outcomes were 
compared for women with obesity and women of healthy weight. We included 
systematic reviews of intervention/experimental studies if the control groups would 
provide outcomes due to obesity. All pregnant women were included, with no age, 
ethnicity or parity restriction, and no language restrictions were used. The outcomes 
measured had to be health outcomes (risks and complications) for the pregnancy, 
mother and/or baby. It was not possible to assess publication bias statistically, by 
funnel plot tests, as review analyses were mixed (e.g., narrative and meta-analyses). 
Similarly, a meta-analysis was not possible due to heterogeneity between reviews 
(particularly in relation to differing definitions of obesity and severe obesity), and 
over-lapping of studies between most reviews, which would have led to double-
counting of data. 
 
A total of 638 reviews was found (159 in PubMed, 50 in CINAHL, 37 in Cochrane 
and 392 in Scopus). Duplicates were excluded and 531 citations were exported to 
EndNote. A first exclusion by title and abstract was made, based on relevancy, using 
the inclusion/exclusion criteria, by CB and JM. A second exclusion based on reading 
the full text was conducted by the whole team, working independently and then 
comparing opinions in pairs:  AD and JM; CB and MB; EO and JM; CB and JM. The 
reference lists of the 112 remaining full-text reviews were searched for additional 
citations, with one further review noted. The 113 reviews were divided into four 
groups, with authors working independently to conduct the full-text screening 
process (based on our inclusion/exclusion criteria), quality assurance and data 
extraction steps, and then comparing decisions with their partner. Eighty-six reviews 
were excluded on full-text screening, as they did not present outcomes for pregnant 
women with obesity, or they did not compare their findings to pregnant women with a 
healthy weight (Figure 1). 
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Quality assessment 
The validated AMSTAR tool (14) was used to assess quality of the studies, based on 
factors such as an a priori design, duplicate study selection and data extraction. 
Each item was given a score of 1 if the specific criterion was met, or 0 if not met, 
unclear, or not applicable. An overall score relating to review quality was calculated 
by summing individual item scores. AMSTAR characterises quality at three levels: 8-
11 is high quality, 4-7 is medium, 0-3 is low quality (15).  
 
Data extraction 
 
Key findings from each review, potential mechanisms for results, and authors’ 
recommendations were extracted, using a data collection form, by teams of two 
reviewers. Disagreements were resolved by discussion, or by recourse to a third 
reviewer. Some reviews included overweight but no data on overweight are 
presented, due to the overlapping of ‘obesity’ and ‘normal weight’ categories 
described below. Outcomes based on only one study are not presented, as that is 
not a review. The same search strategy, but not limited to reviews/meta-analyses, 
was conducted to locate new studies in each topic area to discuss and compare with 
our findings. 
 
 
Results: 
 
We excluded 5 studies that received an AMSTAR score of 3 or less (16, 17, 18, 19, 
20). This left 22 reviews for analysis, 11 with a quality score of 8 to 11 (21, 22, 23, 
24, 25, 26, 27, 28, 29, 30, 31), and 11 with a score of 4 to 7 (32, 33, 34, 35, 36, 37, 
38, 39, 40, 41, 42) (Table 1). 
 
Description of included reviews 
 
Characteristics of the 22 included reviews, with the definitions of obesity used and 
time in pregnancy that BMI was assessed, are presented in Table 1.  
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Definitions of obesity used in the reviews differed, possibly due to the change in the 
Institute of Medicine definition of the obese category from >29 to ≥30 in 2009. In 
addition, one review did not state the definition of obesity (39), 7 reviews had 
included at least one study with an obesity definition down to BMI 25 kg/m², and 7 
included at least one study using a definition of <29/30 kg/m², for their “normal BMI” 
category (Table 1). Authors’ definitions are used throughout. 
 
Reviews were conducted from 2007 to 2014, with included study publication dates 
ranging from 1969 to 2014. Most reviews involved studies from the United States 
(US) and United Kingdom (UK), with wide representation of papers from other 
countries across the world (Table 1). Four reviews presented only a narrative 
synthesis of results (28, 33, 39, 40) and all others performed meta-analyses of crude 
or adjusted data.  
 
The number of studies used in all reviews was 624, an average of 28 studies in each 
systematic review (range 3-70), most of which were case-control or cohort studies. 
Of these, 51 were overlapping (included in more than one review), giving a total of 
573 studies used. The objectives and scope of included reviews varied. Only one 
concerned general outcomes of maternal obesity; most studied specific fetal 
outcomes such as still-birth/death/miscarriage (n=4), and congenital disorders (n=3), 
maternal pregnancy disorders (n=5), and mode of birth (n=3). 
 
Negative health outcomes of obesity in pregnant women  
Gestational diabetes mellitus  
The association between maternal obesity/BMI and gestational diabetes mellitus 
(GDM) was reported in two reviews (35, 27) published in 2007 and 2009, involving 
both low- and high-income countries (Table 1). A total of 76 case-control or cohort 
studies were used after exclusion of over-lapping ones, published from 1992-2006/7. 
In one of the reviews (35), the estimated risk of developing gestational diabetes was 
four times higher among women with obesity (unadjusted ratio: 3.05-4.21) and nine 
times higher (unadjusted ratio: 5.07-16.04) among women with severe obesity (BMI 
from >33 to >40 kg/m2), compared with normal-weight pregnant women. In the 
second review (27), similarly, unadjusted ORs were 3.76, 3.01 and 5.55 higher, 
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respectively, for women with obesity (BMI>29.9 kg/m²), moderate obesity (BMI 30-35 
kg/m2), and morbid obesity (BMI >35 kg/m2), when compared with women of normal 
weight (95% CIs 3.31–4.28, 2.34–3.87, and 4.27–7.21) (27). 
Since the review by Torloni et al, published in 2009 (27), other cohort studies in 
Spain (43), Canada (44), Turkey (45), US (46) and Scotland (47) involving from 931 
to 109,592 pregnant women have shown similar findings, that women with obesity 
are more at risk of GDM. Suggested activities to prevent GDM are diet (48) and 
physical activity (49), and recent systematic reviews (50, 51) and randomised trials  
(52, 53) show positive effects of both in reducing GDM.  
 
Pre-eclampsia and hypertension  
 
Two reviews were included. The 54 case-control and cohort studies involved (after 
exclusion of over-lapping studies) had been conducted in 20 countries, from all 
continents, between the years of 1995 and 2012 (Table 1). One review found a clear 
relationship between increasing BMI and risk of pre-eclampsia with pooled RRs for 
women with obesity (BMI 30-34.9 kg/m2, +/- 0.5 unit), and severe obesity (≥ 35 
kg/m2, +/- 0.5 unit), of 2.68 (95% CI 2.40–3.00) and 3.43 (95% CI 2.59–4.55), 
respectively (29). The second review used narrative synthesis, and found that 
women with obesity were 3-10 times more likely to have pre-eclampsia compared 
with normal weight women, and 4.5-8.7 times more likely to develop gestational 
hypertension (40). The authors believe many factors could cause this increased risk, 
such as insulin resistance, genetics, immunology, nutrition, and infective agents, as 
well as an unhealthy diet and lack of physical activity (40).  
 
Since those reviews, a retrospective study of 120 million women admitted for birth in 
US hospitals showed an increase in pre-eclampsia rates over 30 years, with obesity 
listed as one cause for the increase (54). Two cohort studies in Canada (44) and 
Scotland (47) also observed a positive association between high BMI and gestational 
hypertension and pre-eclampsia, giving credence to our review’s results. 
 
Mode of birth 
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Three reviews were included in this category (24, 37, 38), based on studies 
published 1985 to 2007. Many high-income countries were involved, and all reviews 
included United States (US) and United Kingdom (UK) studies. Sixty-two cohort, 
case-control and randomised controlled trial (RCT) studies were used, after 
exclusion of over-lapping studies (Table 1). The unadjusted odds ratio (OR) for 
women with obesity having CS compared with women of normal weight was found to 
be from OR 2.01, 95% CI 1.87 – 2.15) (36), up to OR 2.36, 95% CI 2.15-2.59 (23), 
compared with normal weight pregnant women (Table 2). Similarly, Chu et al (37) 
found unadjusted ORs in women with obesity (BMI >29 to 39.9) and severe obesity 
(BMI >35 to >40 kg/m2) of 2.05, 95% CI 1.86–2.27 and 2.89, 95% CI 2.28–3.79, 
respectively. The Heslehurst review (38) also found increased odds in women with 
obesity compared with women of ideal weight in instrumental vaginal births (OR 
1.17, 95% CI 1.13-1.21) (Table 2). 
 
The increase in CS and instrumental vaginal birth were suggested to be due to: a 
possible link between increased cholesterol deposits in the myometrium of women 
with obesity, affecting contractions (24); an increase in maternal soft tissue inside the 
pelvis narrowing the birth canal and increasing difficult births especially with a 
macrosomic infant, or a poorer response to oxytocin administration (37).  
 
Associations between obesity and increased rate of CS have been observed in 
several more recent studies, published after the latest review in 2009 (24). The 
studies span many different countries and all indicate the same increased rate of CS 
in women with obesity (43, 45, 47, 55, 56, 57, 58), reinforcing these results. 
 
Surgical site infection   
  
Two reviews were included (33, 39), with a total of 22 studies after over-lapping ones 
were removed, from 22 countries, published 1990-2012. Both reviews used narrative 
synthesis. One (39) found a significant association between obesity and surgical site 
infection (SSI) in two studies only, and four other studies did not find this association. 
The second review (33) showed that 12 of the 13 studies supported a relationship 
between obesity and SSI (Table 2).  
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The two studies demonstrating an association in the first review (39), were not 
included in the second review (33). Since the latest of those reviews (33), further 
studies have demonstrated similar results (59, 60) and indicated that these infections 
may require prophylactic treatment (61).  
 
Mental health 
 
One review and meta-analysis included 62 cohort, case–control, cross-sectional, and 
intervention studies with 540,373 antenatal or postnatal women from countries 
worldwide, ranging from 2000-2013 (32) (Table 1). Women with obesity had elevated 
odds of both antenatal (OR 1.43, 95% CI 1.27–1.61) and postnatal (OR 1.30, 95% CI 
1.20–1.42) depression, compared to women of healthy weight. For antenatal anxiety, 
meta-analysis findings suggested that women with obesity had higher risk compared 
to healthy weight women (OR 1.41, 95% CI 1.10–1.80). Too few studies were found 
to merit a meta-analysis for postpartum anxiety, antenatal binge eating disorder and 
serious mental illness. Qualitative research suggests that women are aware of the 
elevated health risks associated with their obesity, which may lead to increased 
anxiety levels (62). Other suggestions for mental ill-health during pregnancy are that 
pregnant women feel stigmatised for their overweight during pregnancy, which in 
turn may exacerbate their depression and/or anxiety (23). However, a reverse causal 
pathway cannot be ruled out, as women with poor mental health also struggle with 
weight management (23).   
 
 
Pre-term birth  
 
Three reviews (26, 38, 31) examined links between maternal BMI and pre-term birth, 
including 133 cohort and case-control studies after over-lapping ones removed. 
Studies came from more than 45 countries, and were published 1988-2008 (Table 
1). One review found a significant increase in the risk of spontaneous pre-term birth 
<32 weeks gestation for women with BMI ≥40 kg/m2 (adjusted odds ratio (AOR) 
2.27, 95% CI 1.76-2.94). The authors found that, even after adjusting for 
confounding variables, women with BMI ≥35 kg/m2 had a 33% higher risk of pre-term 
birth for all reasons than women with normal weight (AOR 1.33, 95% CI 1.12-1.57) 
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(26). The second review found that birth at <37 weeks was linked with obesity (OR 
1.226, 95% CI 1.149-1.308) and morbid obesity (BMI >40 kg/m2), OR 1.495, 95% CI 
1.41-1.59) (38). The third review presented most overweight and obesity results 
combined; however, the adjusted relative risk of obese and very obese women (BMI 
≥34.9 to ≥40 kg/m2) having a pre-term birth before 33 weeks’ gestation was 1.49, 
95% CI 0.89-2.50, and 2.02, 95% CI 1.24-3.29, respectively, based on pooling 2 
studies (31).  
 
More recent studies from Turkey, Sweden and US (45, 63, 64) are generally in line 
with these results. Reasons are complex and may be influenced by gestational age, 
race/ethnicity and parity (64), or the interaction of genetic and environmental factors 
(26). One small study of 253 women in US (65) found opposing results, showing pre-
term birth to be decreased in women with obesity, a result that may be due to 
chance, caused by the small sample size, or due to their definition of pre-term birth 
as ‘before 35 weeks’. Overall, the results of our review appear to show an increase 
in spontaneous pre-term birth, which may contribute to the increased requirement for 
neonatal intensive care noted in the Heslehurst review (38). 
 
Infant birth weight 
 
Three reviews of cohort, case-control, and cross-sectional studies were found 
concerning pre-pregnancy BMI and infant birth weight (30, 38, 31), including 82 
studies after over-lapping ones removed. At least 48 countries were involved, but not 
all reviews provided this information, and publication dates went from 1988-2012 
(Table 1). In one review (30), pre-pregnancy obesity decreased the risk of low birth 
weight (below the 10th centile) (OR 0.81, 95% CI 0.80–0.83) and increased the risk 
of large for gestational age (above the 90th centile) (OR 2.08, 95% CI 1.95–2.23), 
compared with normal weight women. Pre-pregnancy obesity also increased the risk 
of high birth weight (>4,000g) (OR 2.00, 95% CI 1.84–2.18), and macrosomia 
(>4,500g) (OR 3.23, 95% CI 2.39–4.37). High birth weight (undefined) was also 
linked with obesity in the second review, (OR 2.357, 95% CI 2.293-2.422) and the 
risk of low birth weight was decreased (OR 0.84, 95% CI 0.782-0.905) (38).  
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The third review presented most overweight and obesity results combined (31). The 
pooled crude data gave a relative risk of having a low birth weight baby (<2,500g) for 
obese and very obese women (BMI ≥ 34.9 to ≥ 40 kg/m2) as 0.63, 95% CI 0.34 to 
1.19, and 0.81, 95% CI 0.42 to 1.53, respectively, based on pooling 4 and 5 studies. 
Although the review did document the risk of having an extremely low birth weight 
baby (<1000g) for obese and very obese women separately (31), it was based on 
one study and so is not presented here. When authors accounted for publication 
bias, the apparent protective effect of obesity on low birth weight was no longer 
seen (31).  
 
Since publication of those reviews, a study in Romania (n=500) found a higher 
incidence of intrauterine growth restriction in pregnancies of women with obesity 
(66). This unusual finding may be due to chance; a result of the small sample size, or 
perhaps due to co-morbidity of the mothers. Two large US studies, published since 
the two reviews (30, 31), found that pregnant women with obesity had reduced odds 
of having small for gestational age babies (67) or a greater prevalence for large-for-
gestational age babies (68). On balance, it would appear that the reviews’ (30, 31, 
38) conclusion that pre-pregnancy obesity decreases the risk of low birth weight (as 
all babies of women with obesity tend to be bigger than average) is most likely to be 
correct, but the effect may be small. 
 
Fetal defects (malformation) and congenital anomalies   
 
Three reviews were included (25, 28, 42), involving at least 11 countries (one study 
mentioned Scandinavia but did not fully describe the countries). Fourteen cross-
sectional, case-control and cohort studies were used excluding ones over-lapping, or 
non-related to maternal obesity, all published 1969-2010 (Table 1). No effect of BMI 
was found on esophageal atresia, diaphragmatic hernia, hypospadias, microcephaly, 
tetralogy of Fallot, transposition of the great arteries or microtia/anotia (25). The 
prevalence of gastroschisis was significantly lower among mothers who had obesity 
(OR 0.17, 95% CI 0.10-0.30) (25). Van Lieshout’s review included only two relevant 
studies, neither of which showed any increased risk of fetal alcohol syndrome in 
babies of mothers with obesity (28). The third review had three studies of relevance 
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and found a significant association for anorectal anomalies in the fetus of mothers 
with obesity (OR 1.64, 95% CI 1.35-2.00), based on two studies (42) (Table 2). 
 
It should be noted that two of the reviews (28, 42) were based on only three studies 
each but the third (25) was larger (18 studies) and of high quality. The review by Van 
Lieshout et al (28) described limitations of the two studies reviewed, including that 
the case and control mothers differed in demographic variables such as socio-
economic status and education, and the authors had not controlled for important 
confounders. Confirming the results of the reviews, however, are some recent 
studies showing an increase in fetal neural tube defects in women with obesity (69, 
70, 71, 72).  Cardiac defects were also increased in babies of women with obesity in 
four studies from US, Australia, and Sweden (73, 74, 70, 72). In sum, it would 
appear that obesity increases the risk of some fetal defects and congenital 
anomalies. Stothard et al suggested nutritional deficiencies, especially reduced 
levels of folic acid, as a reason for congenital anomalies. Other possible reasons 
given were hyperglycaemia and undiagnosed diabetes in pregnant women with 
obesity. The authors also suggested that, as performing ultrasound scans is more 
difficult in women with obesity, this could lead to fewer terminations of pregnancy for 
fetal abnormality (25).  
 
Fetal death, miscarriage and stillbirth   
  
Four reviews investigated the risk of maternal obesity on stillbirth (21, 22, 36), 
miscarriage (34) and fetal death (21). Observational, cross-sectional, cohort and 
case-control studies (n=136) were included after overlapping papers were removed, 
all published 1988-2014. Two of the reviews included studies only from high-income 
countries (34, 22), the other two included low-income countries in Latin America and 
Africa also (21, 36) (Table 1). The review of studies on miscarriage showed an 
association with maternal obesity with a pooled OR for BMI ≥ 28 or BMI ≥ 30 of 1.31 
(1.18-1.46) (34). Fetal death demonstrated a RR for women with a BMI ≥ 30 of 1.34 
(1.22-1.47), and for those with BMI ≥ 35 and ≥ 40, RRs of 1.97 (1.71-2.28) and 3.54 
(2.56-4.89) (21) (Table 2). 
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The odds ratio/relative risk of stillbirth in women with obesity (BMI ≥ 30 kg/m2) varied 
from RR 1.46 (1.37-1.55) (20), to AOR 1.6 (1.35-1.95) (21) and OR 2.07 (1.59-2.74) 
(34). One review found that women with severe (BMI ≥ 35 kg/m2) and morbid (BMI ≥ 
40 kg/m2) obesity had higher RRs for still-birth of 1.78 (1.67-1.91) and 2.19 (2.03-
2.36), respectively (21). 
 
The four reviews agreed on many potential mechanisms for the results found. Two 
agree on the point that obesity during pregnancy itself increases the risk for maternal 
co-morbidities that are risk factors for stillbirth and miscarriage (21, 36). Another 
theory discussed in two reviews was the possibility that thinner women could have a 
better ability to feel a decrease in fetal movements, and would thus seek care as 
soon as movements declined (21, 36).  
 
We found three studies published after those reviews. Two supported the 
relationship between maternal obesity and increased rates of neonatal/perinatal 
death (75, 45), and a large cohort study of singleton births (n=2,868,482) found rates 
of stillbirth increased with increasing BMI (76), thus confirming our review’s results.  
 
Miscellaneous outcomes 
 
One moderate-quality review (38), involving 49 studies from 15 countries, published 
1990-2007 (Table 1), found an increased risk of birth over 41 to 42 weeks gestation, 
increased rates of induction of labour, more frequent use of oxytocin augmentation 
and higher incidence of failure to progress in labour in women with obesity compared 
with those of healthy weight (38). Also found was that babies of women with obesity 
needed neonatal intensive care more often, and had higher rates of fetal 
compromise and meconium stained liquor. Women with obesity compared with those 
of ideal weight had a higher risk of postpartum haemorrhage and a longer duration of 
hospital stay (2.84 days (95% CI 2.77-2.91) compared with 2.4 days for normal 
weight women) (Table 2). 
 
Longer duration of hospital stay in women with obesity has also been found in 
Scottish (47), and Australian (9) studies, which leads to higher healthcare costs (77). 
Denison et al (47) computed extra costs to the Scottish health services to be £59.89 
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(£41.61-78.17), £202.46 (£178.61-226.31), and £350.75 (£284.82-416.69), 
respectively, for women who were overweight (BMI 25 <30 kg/m2), obese (30 <40 
kg/m2), or severely obese (≥40 kg/m2) (euro and dollar equivalents €75.33/$94.27, 
€254.64/$318.67 and €441.15/$552.08 respectively). 
 
 
Breastfeeding  
 
Two systematic reviews, of moderate quality, were included (32, 41), with 29 studies 
from nine different countries, when the 11 overlapping studies were removed. Cohort 
studies, surveys, reviews of medical records, and database studies were considered, 
all published 1989-2011 (Table 1). Women with obesity were less likely to initiate 
breastfeeding than normal weight women, with ORs from 1.38-3.09 in one review 
(32) and 1.19-3.65 in the second (41). Seven out of 15 studies in one review (32) 
found that women with obesity breastfed for a shorter duration than did women with 
normal weight, and the second found an increase in early cessation of breastfeeding, 
with a range of hazard ratios from 1.24-2.54 (41) (Table 2). 
 
The review authors suggest the reasons that women with obesity may have difficulty 
in breastfeeding may be physiological, behavioural, socio-cultural, psychological and 
medical (32, 41). For example, women with obesity may have elevated progesterone 
levels which may prevent the usual fall in progesterone following birth that leads to 
lactogenesis (32). Large breasts may also make latching on more difficult (32). There 
may also be complex socio-cultural reasons why women with obesity are less likely 
to breastfeed successfully, such as lower socio-economic group, not having been 
breastfed themselves, smoking, low self-esteem, poor mental health or solely that 
they may feel more uncomfortable breastfeeding in public (32).  
 
Studies published after the most recent review (41) confirm that women with obesity 
had lower initiation rates and were at greater risk of stopping breastfeeding than 
women of normal weight (78, 79, 80, 81, 82, 83). One study found that women with 
high pre-pregnant BMI tend to breastfeed for shorter durations due to lack of comfort 
or confidence with their body image (79).  
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Discussion 
This review of reviews has presented the health risks for women with obesity and 
their fetuses/babies. Risks include gestational diabetes (identified as a risk factor in 
one moderate and one high-quality review, based on 76 studies (27, 35)), gestational 
hypertension and pre-eclampsia (54 studies in one moderate and one high-quality 
review (40, 29)), and mental ill-health expressed as antenatal anxiety and 
depression, and postpartum depression (62 studies in one high-quality review (23)). 
At birth, the odds for caesarean section were increased, ranging from 2-2.36 in three 
included reviews (37, 38, 24), one of high quality and two of moderate, including 62 
studies. An increase in instrumental birth was also noted (38).  
 
Surgical site infection was increased after CS (two reviews 33, 39, using narrative 
synthesis only and both of moderate quality, based on 22 studies). Breastfeeding 
was less likely to be initiated and/or maintained (two moderate-quality reviews (32, 
41), based on 29 studies, with findings corroborated by recent research (78, 79)). 
 
The health risks for babies of mothers with obesity include an increase in the risk of 
pre-term birth (<32, <33 and <37 weeks gestation) for all women with obesity, shown 
in the one moderate and two high-quality reviews identified (26, 31, 38), based on 
133 studies. Also found was an increase in the risk of larger ‘large for gestational 
age’ babies (30, 38) and a decrease in the risk of low birth weight (30), in the one 
moderate and one high-quality review, covering 82 studies. Two reviews (25, 42), 
one moderate and one high-quality, based on 14 studies, found that obesity in 
mothers pre- and during pregnancy was a significant predictor of 
neurodevelopmental problems or malformations in the children (Table 2). These 
problems include ‘neural tube defect (NTD), anencephaly, spina bifida, 
cardiovascular anomaly, septal anomaly, cleft palate, cleft lip and palate, anorectal 
atresia, hydrocephaly, limb reduction anomaly” (25, p.646) and anorectal anomalies 
(42), but not fetal alcohol syndrome (28). In addition, four reviews (two moderate and 
two high-quality, including 136 studies) found that maternal obesity increased the 
incidence of stillbirth (21, 36, 22), miscarriage (34) and fetal death (21), and more 
recent studies supported these results (45, 75, 76). 
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A key cause for women with obesity having higher rates of GDM is that they tend to 
have a less healthy diet and take less physical activity. As authors of two reviews 
also believe that hyperglycaemia, undiagnosed diabetes (25) or nutritional 
deficiencies (25, 42) may be causative factors for fetal malformation, increased 
promotion of taking folic acid, a healthy diet and sufficient exercise for all women 
planning pregnancy should be instigated, as a matter of policy. Women should also 
be supported, through national subsidised programmes, to lose weight before they 
conceive and to control their weight in pregnancy. Research into this area of care is 
currently scant (84, 85) and indicates that weight advice is seldom provided (86). 
Despite this, there are some promising intervention findings regarding women’s 
improvements in healthy eating and physical activity (87, 88). Interventions targeting 
pregnant women with obesity should take into consideration the potential poor 
mental health of these women, who may have disordered eating and thus need extra 
support (89). In relation to breastfeeding, clinicians do not appear to provide extra 
support (90) to women with obesity, nor do they always seek help (78), so health 
care professionals need to identify women who may struggle breastfeeding, and 
provide extra assistance. 
 
Comprehensive, updated systematic reviews on gestational diabetes in women with 
obesity, the risk of CSs and instrumental births to women with obesity, and the risk of 
pre-term birth should now be repeated, as the latest studies in reviews considered 
here were published in 2006-8. A revised systematic review on pre-eclampsia in 
women with obesity, including the results of three large recent studies (44, 47, 54), 
would also be useful. Although two narrative reviews presented here showed that 
surgical site infection was increased in women with obesity (33, 39), five studies in 
those reviews showed no association, and more recent studies have been 
conducted (59, 60). There is, therefore, a need for a new systematic review on SSI in 
relation to obesity in pregnancy, including a meta-analysis, if possible. 
 
Further research is needed into the causes and management of depression in 
pregnant and postpartum women with obesity, particularly as there may be a reverse 
causal pathway, where women with poor mental health have difficulty with weight 
management (23).  More research is also needed on specific interventions targeting 
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the reduction of gestational diabetes in women with obesity, and into how race, 
ethnicity and parity may influence rates of pre-term birth.  
 
As many of the studies included in the reviews on breast-feeding did not control for 
confounding variables (32), further research is needed. More qualitative studies are 
also recommended regarding these women's perspective in order to understand their 
infant feeding decisions and behaviour (41, 32). Recent trials of interventions such 
as peer counselling or extra support targeted at women with overweight or obesity 
(91, 92) did not find it improved breastfeeding rates or continuation of breastfeeding. 
However, as a Cochrane systematic review has shown that such support given to 
women irrespective of weight status is effective (93), further research is needed to 
develop feasible and acceptable interventions for women with obesity. 
 
Review strengths and limitations 
 
To our knowledge, this is the first review of reviews summarising the risks associated 
with maternal obesity. The key strength is the amount and quality of literature from 
all languages that has been gathered together, summarised and discussed critically, 
including reference to recent trial results. The result is a succinct, exhaustive and 
extensive review that includes both mother and baby outcomes, and physical and 
mental health. The inability to perform a meta-analysis is a limitation, but was not 
possible due to heterogeneity between reviews (particularly in relation to differing 
definitions of obesity and severe obesity), and over-lapping of studies between most 
reviews, which would have led to double-counting of data. We have limited the 
outcomes to maternal obesity compared to normal weight pregnant women without 
reference to women who are overweight, as some studies included in the reviews 
had ‘overweight’ categories that overlapped with normal or obese definitions. We 
have not used grey literature, but think it unlikely that there are unpublished 
systematic reviews in this area. Importantly, we focused on maternal obesity, but 
excessive gestational weight gain may also be an issue, that can exacerbate some 
of these health risks.  
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Conclusions and recommendations 
 
The negative impact of obesity before and during pregnancy on mothers’ and their 
babies’ health is clear. Health conditions such as gestational diabetes, pre-eclampsia 
and gestational hypertension are common in pregnant women with obesity. There is 
also an increased rate of instrumental and caesarean section births, and a greater 
rate of surgical site infections and antenatal and postnatal depression. The risk of 
large for gestational age babies is higher, and lower breastfeeding initiation rates 
and shorter breastfeeding duration are also seen. In addition, obesity is linked to a 
greater risk of pre-term birth, fetal defects, congenital anomalies, and perinatal 
death. These adverse outcomes lead to increased costs, due to longer duration of 
hospital stay and higher treatment costs. Investing in national subsidised 
programmes aimed at supporting women to lose weight before they conceive, and 
control their weight in pregnancy, may thus confer long-term health and monetary 
benefits. 
 
Research that is needed in this area, in addition to updates systematic reviews, 
includes: qualitative studies on women's perspectives of breastfeeding, in order to 
understand their infant feeding decisions and behaviour, and explorations of why 
pregnant women with obesity suffer from poorer mental health compared to those of 
healthy weight. Research into effective pre-conception interventions to help women 
with obesity lose weight before they conceive, and between pregnancies, is also 
essential, in order to reduce the burden of maternal and fetal outcomes caused by 
maternal obesity.  
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Figure 1: Study flow diagram  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
638 records found 
through systematic 
database search  
107 
duplicates 
found 
531 records 
screened based 
on title and 
abstract 
 
112 full text articles 
assessed. One 
further review was 
identified from 
reference lists 
(n=113) 
  
420 records 
excluded 
22 papers included 
in the systematic 
review  
91 papers 
excluded (86 
on full-text 
and 5 on 
quality 
assessment) 
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Table 1. Characteristics of 22 included reviews 
First 
author, 
Year  
AMSTAR 
score 
Time 
frame of 
searche
s, and 
date 
range of 
include
d 
studies  
Scope of 
review 
Population  
(data on 
overweight 
excluded) 
Range of 
definitions 
of ‘normal 
BMI’ used 
by included 
studies 
Range of 
definitions 
of ‘obesity’ 
used by 
included 
studies 
Time BMI 
measured/ 
assessed in 
pregnancy 
Number of 
included 
studies  
Sample 
size  
Location: 
countries or 
group of 
countries 
Type of 
studies 
included 
Amir, 
2007 
Score: 4 
Inceptio
n to 
Jan/Feb 
2007  
 
Range 
1989- 
2006 
Breast 
feeding 
intention, 
initiation 
and 
duration 
Pregnant 
women with 
data on 
maternal 
obesity and 
lactation/ 
breast 
feeding 
20-25 kg/m²  
– lowest  
<26.1 kg/m²  
– highest 
 
 
25- <30 
kg/m²    – 
lowest 
BMI > 30 
kg/m²   - 
highest 
Pre-
pregnancy 
(8); ‘at time 
of interview’ 
(3); post-
partum (2); 
antenatal 
booking (1);  
not stated (2) 
 
16 studies 
(22 in full 
review) 
(N = N/A) 
US, Australia, 
Russia, 
Kuwait, 
Denmark 
 
Cohort 
studies, 
surveys, 
medical 
records and 
database 
studies 
Anderson, 
2013 
Score: 8 
2002 to 
2012 
 
Range 
2002-
2012 
Risk of 
surgical site 
infection 
(SSI)  
Pregnant 
women with 
obesity 
undergoing 
caesarean 
section. 
19.8-24.9 
kg/m²   – 
lowest 
≤30 kg/m²  – 
highest 
                             
≥25 kg/m² – 
lowest             
> 30 kg/m²   - 
highest 
 
Admission to 
hospital (2); 
pre-
pregnancy 
(2); BMI gain 
during 
pregnancy 
(1) 
Time not 
stated (8) 
13 studies 
(N = 
225,949) 
UK, US, 
Canada, 
Israel, Norway, 
Denmark, 
Nigeria, Egypt, 
India, China 
 
Cohort, 
case-
control 
study, 
nested 
case-
control 
study, 
register 
study 
Aune, 
2014 
Score: 9 
Inceptio
n to Jan 
2014 
 
 
Range 
1992-
2014 
Risk of fetal 
death, 
stillbirth, 
perinatal, 
neonatal 
and infant 
death 
Women with 
BMI reported 
before or in 
early 
pregnancy  
18.5-<23 
kg/m²– 
lowest             
19.8 - 26 
kg/m²  – 
highest 
 
 
≥25 kg/m² – 
lowest             
>30 kg/m² - 
highest 
Pre-
pregnancy or 
early in 
pregnancy 
38 studies  
(44 
publications
)  
(N = N/A) 
 
 
UK, Sweden, 
Denmark, 
Latin America, 
India, Finland, 
Korea, 
England, 
Spain 
Australia, US, 
China, 
Cohort 
studies 
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Canada, 
Argentina, 
Zambia, 
Northern 
Ireland, 
Scotland 
Boots, 
2011 
Score: 6 
 
1948 to 
2011 
Range 
1988-
2010 
 
Risk of 
miscarriage  
Women with 
obesity (BMI 
≥28 /≥30) 
who 
conceived 
spontaneousl
y 
18.5 – 24.9 
kg/m²– 
lowest             
19 – 24.9 
kg/m²  – 
highest 
 
≥28 kg/m² – 
lowest             
≥ 30 kg/m² - 
highest 
Time not 
stated (6) 
6 studies 
(N= 
28,538) 
US, Canada, 
UK 
Cohort , 
Case-
control 
studies 
Chu, 2007 
(a) 
Score: 4 
1980 to 
Jan 
2006 
Range 
1992-
2006 
Risk of 
GDM 
Pregnant 
women with 
obesity and 
severe 
obesity 
18–24.9 
kg/m2 – 
lowest             
22–28 kg/m²  
– highest 
 
 
>29 kg/m² – 
lowest             
>35 kg/m² - 
highest 
Pre- 
pregnancy or 
during the 
first trimester 
or first 
prenatal visit 
20 studies 
(N= 
844,295) 
US, Canada, 
Australia, Italy, 
France, United 
Arab Emirates, 
Israel, Finland, 
Nova Scotia, 
UK 
Case 
Control or 
Cohort 
studies 
(pro- and 
retro-
spective) 
Chu, 2007 
(b) 
 Score: 4 
1980 to 
Sep 
2005 
Range 
1993-
2005 
 
Risk of 
stillbirth 
 
Women with 
BMI reported 
before, or in, 
pregnancy 
18.1–22 
kg/m2 – 
lowest             
22–28 kg/m² 
– highest 
 
 
29.1-35 
kg/m² – 
lowest             
>30 kg/m² - 
highest 
Pre- 
pregnancy or 
during the 
first trimester 
or first 
prenatal visit 
9 studies 
(N= 
1,031,804) 
US, Sweden, 
Norway, 
Benin, 
Denmark, 
United Arab 
Emirates, UK, 
France 
Cohort  or 
case-
control 
studies 
Chu, 2007  
(c) 
Score: 4 
1980 to 
2005 
 
Range 
1985-
2005 
 
Risk of 
caesarean 
birth 
Maternal 
obesity 
 
18.5–24.9 
kg/m²– 
lowest  
<29 kg/m²  – 
highest 
 
 
29–39.9 
kg/m² – 
lowest             
>35 kg/m² - 
highest 
Pre- 
pregnancy or 
during the 
first trimester 
or first 
prenatal visit 
33 studies 
(N= 
1,391,654) 
 
US, Sweden, 
France, 
Denmark,  
Israel, 
Canada, UK, 
Poland,  
United Arab 
Emirates 
Cohort, 
Case-
control 
studies 
Flenady, 
2011 
Score: 8 
1998 to 
2009 
Range 
Risk factors 
for stillbirth 
in high 
Population-
based 
studies 
<25 kg/m² 
 
 
 > 30 kg/m Second 
trimester, or 
at booking 
4 studies 
(96 in the 
full review) 
US, Sweden, 
UK 
Cohort, 
Case-
control 
 36 
 
1993-
2009 
income 
countries 
addressing 
risk factors 
for stillbirth 
(N = N/A) studies 
Heslehurs
t 2008 
Score: 7 
 
1990 to 
2007 
 
Range 
1990-
2007 
 
Impact on 
short-term 
obstetric 
and 
neonatal 
outcomes 
in women 
with obesity  
Pregnant 
women with  
maternal 
weight or 
BMI recorded 
< 16 
gestational 
weeks 
18–24.9 
kg/m² lowest    
20–30 kg/m²  
– highest  
 
 
25-30 kg/m² 
– lowest          
>30 kg/m² - 
highest 
First 
trimester 
(recorded 
before 16 
weeks of 
pregnancy) 
49 studies 
(N = N/A) 
Abu Dhabi, 
Australia, UK, 
Austria, Brazil, 
Canada, Iran, 
Denmark, 
Italy, Finland, 
France, Israel , 
Sweden, 
Thailand, USA 
Cohort 
studies 
Lakhan, 
2010 
Score: 5 
 
 
1990 to 
2007 
Range 
1990-
2006 
Risk of 
surgical site 
infection 
(SSI) 
following 
CS 
 
Women who 
had 
caesarean 
section 
 
 
Not stated Not stated Time not 
stated 
9 studies 
(15 in full 
review) 
(N = N/A) 
Italy, New 
Zealand, 
Saudi Arabia, 
UK, USA, 
Vietnam  
Prospective 
observation
al cohort 
studies; 
RCTs  
 
McDonald
, 
2010 
Score: 9 
1950 - 
2009 
 
Range 
1989-
2008 
Risk of 
preterm 
birth and 
low birth 
weight. 
Women with 
obesity and 
preterm birth 
(<37 weeks) 
or low birth 
weight  
(<2500 g) 
18.3–29.8 
kg/m²– 
lowest             
<29 kg/m²  – 
highest  
 
 
 
>24 kg/m² – 
lowest             
>40 kg/m² - 
highest 
 
Time not 
stated for the 
5 studies 
included in 
this review 
(5 studies 
(84 in full 
review) 
N=  
1,095, 834  
Not stated for 
the 5 studies 
included in this 
review  
Cohort and 
case 
control 
studies 
Molyneau
x, 2014 
Score: 9 
Inceptio
n to Jan 
2013 
Range 
2000-
2013 
Risk of 
antenatal 
and 
postpartum 
mental 
disorders 
Studies 
assessing 
antenatal  or 
postpartum 
mental 
disorders in 
women with 
obesity 
18.5–25 
kg/m² – 
lowest 
20‐ 25 kg/m² 
highest 
 
>29 kg/m²  – 
lowest   
>32.3 kg/m² - 
highest 
 
1 year 
before 
pregnancy or 
during the 
first trimester 
62 studies  
(N=75,108) 
 
  
North America, 
Australasia, 
South 
America, Asia, 
Europe (not 
fully reported) 
Cohort, 
Case–
control, 
Cross-
sectional, 
and 
Intervention 
studies 
Poobalan, 
2009 
Score: 8 
1996 to 
2007 
 
Range 
Increasing 
maternal 
BMI and 
risk of 
Nulliparous  
pregnant 
women with 
obesity 
19.8–26 
kg/m² – 
lowest             
20–30 kg/m²  
>29 kg/m² – 
lowest             
>30 kg/m² - 
highest 
Pre-
pregnancy or 
at booking 
visit 
11 studies  
(N=20,419) 
USA, UK, 
Denmark, 
Sweden  
Cohort 
studies (3 
prospective
) 
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1998-
2007 
 
elective/ 
emergency 
caesarean 
birth 
– highest  
 
 
 
 
 
Salihu, 
2012 
Score: 5 
 
1992 to 
Dec 
2011 
 
Range 
1995-
2011 
Risk of pre-
eclampsia, 
casual 
mechanism 
or pathway 
Pregnant 
women 
18.5–24.99 
kg/m² – 
lowest             
<25 kg/m²  – 
highest  
 
 
>30 kg/m² – 
lowest             
>45 kg/m² - 
highest 
Pre-
pregnancy 
(15); first 
trimester 
(2);booking    
visit  (1); 
postpartum 
(1); time not 
stated (2) 
21 studies 
(N = N/A) 
Italy, 
Germany, 
Australia, 
Israel, France, 
Saudi Arabia, 
Canada, 
Netherlands, 
Zimbabwe, 
US, Denmark, 
UK, Sweden, 
Czech 
Republic, 
Pakistan, 
Brazil 
Prospective 
cohort 
studies 
Stothard, 
2009 
Score: 9 
 
1966 to 
2008 
 
Range 
1969-
2007  
 
Risk of 
congenital 
anomaly 
Women with 
pre-
pregnancy/ 
early 
pregnancy 
weight/BMI 
measured  
18.1–28.3 
kg/m²– 
lowest             
≤29 kg/m²  – 
highest  
 
 
≥28 kg/m² – 
lowest             
≥31kg/m² - 
highest 
Pre-
pregnancy 
(26); booking 
visit (6); 2nd 
trimester (1); 
time not 
stated (7) 
39 in full 
review, 18 
in meta-
analysis 
(N = N/A) 
UK, US , 
Canada, 
Sweden, 
Spain, 
Australia 
Case 
control, 
Cohort 
studies 
Torloni, 
2009 (a) 
Score: 9 
1968 to 
Jan 
2008 
 
 
Range 
1988-
2008 
 
Risk of 
preterm 
birth (PTB) 
Unselected 
or low-risk 
women with 
pre-gravid 
BMI 
measured 
20-24.9 
kg/m²  
(categories 
for individual 
studies not 
given) 
 
 
>30kg/m²  
(categories 
for individual 
studies not 
given) 
Pre-
pregnancy 
BMI 
39 studies 
(40 articles)   
(N= 
1,788,633) 
32 from 
developed 
countries (not 
fully reported) 
and the rest 
from 
Argentina, 
Iran, Mexico, 
United Arab 
Emirates, 
Qatar, Trinidad 
Cohort, 
Case-
control 
studies 
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Torloni, 
2009 (b) 
Score: 10 
 
1977 to 
March 
2007 
Range 
1992-
2007 
 
Risk of 
GDM 
Women with 
pre-
pregnancy or 
first trimester 
BMI 
measured 
<18.5 kg/m²– 
lowest             
<30 kg/m²  – 
highest  
 
 
25 –29.9 
kg/m² – 
lowest             
>32.9 kg/m² - 
highest 
Pre-
pregnancy or 
first trimester 
BMI  
70 studies  
(N= 
671,945) 
53 high-
income and 17 
low-middle-
income 
countries (not 
fully reported). 
Case-
control, 
Cohort 
studies 
Turcksin, 
2012 
Score: 5 
1996 (or 
1997) to 
2011 
Range 
1997-
2011 
Breast 
feeding  
Low-risk 
mothers with 
obesity or 
normal 
weight 
18.5–24.9 
kg/m²     - 
lowest 
19.8–26.0 
kg/m² - 
highest    
>29.0 kg/m²     
- lowest 
 ≥30.0 kg/m² 
- highest    
Pre-
pregnancy 
(13); at time 
of interview 
(postpartum) 
(4); time not 
stated (2) 
18 studies 
(19 papers) 
(N = N/A) 
US, Australia, 
Russia, 
Denmark, 
Greece, 
France, 
Belgium 
Pro- and 
retrospectiv
e cohort 
studies 
Van 
Lieshout, 
2011  
Score: 8 
From 
inceptio
n to Sep 
2010 
Range 
1998-
2010 
 
Risk of 
neuro-
developme
ntal 
problems in 
offspring  
All pregnant 
women  
19-29 kg/m²– 
lowest  
20–27 kg/m² 
- highest 
 
 
>29 kg/m² – 
lowest             
>30 kg/m² - 
highest 
Pre-
pregnancy 
(7); first (2), 
second (2), 
or third (1) 
trimester 
(self-reported 
or measured) 
3 studies 
(12 in the 
full review)  
(N = N/A) 
US, Finland, 
South Africa, 
Scandinavia 
(not fully 
reported) 
Sweden, US, 
Japan, Italy, 
Australia 
Case-
control, 
Cohort 
studies 
Wang, 
2013  
Score: 10 
Inceptio
n to Jun 
2012 
 
Range 
1997-
2012 
Risk of pre-
eclampsia 
Pregnant 
women 
20-24.9 
kg/m² (+/- 0.5 
unit 
deviation) 
 
 
30-34.9 
kg/m² 
(+/- 0.5 unit 
deviation) 
 
Pre-
pregnancy or 
early 
pregnancy  
29 studies  
(N= 
1,980,761) 
US, Australia, 
Netherlands, 
Brazil, 
Sweden, 
Denmark, 
Norway, Israel, 
Argentina, 
Saudi Arabia, 
Ireland, New 
Zeland, UK 
Prospective 
cohort 
studies 
Yu, 2013  
Score: 9 
1970 to 
Nov 
2012 
 
Range 
2001-
Birth weight 
of infants  
All pregnant 
women 
18.5–22.9 
kg/m²– 
lowest             
19.8–26 
kg/m²  – 
highest  
≥25 kg/m² – 
lowest             
≥30 kg/m² - 
highest  
Pre-
pregnancy 
45 studies 
(N = N/A) 
UK, Sweden, 
Denmark, 
USA, 
Germany, 
Saudi Arabia, 
China, Turkey, 
Cohort, 
Case-
control, and 
Cross-
sectional 
studies 
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2012  
 
South 
Australia, Iran, 
Sudan, Korea, 
India, 
Thailand, Italy, 
Pakistan, 
France, 
Canada, 
Croatia 
Zwink, 
2011  
Score: 7 
N/A 
Range 
1981-
2010 
Risk of 
anorectal 
mal-
formations 
in offspring  
All pregnant 
women 
18.5 - <25 
kg/m² 
 
 
≥30.0 kg/m² Pre-
pregnancy  
 3 studies 
(22 in full 
review) 
(N = N/A) 
US, Sweden, 
Netherlands  
Case-
control, 
Cross-
sectional 
studies 
RCT=randomised controlled trial, PTB=preterm birth, GDM=gestational diabetes mellitus, N/A=not available 
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Table 2. Outcomes of maternal obesity compared with normal maternal BMI 
First 
author, 
Year 
Key findings reported  
OR/RR (95% Confidence Interval) 
Potential mechanisms suggested by authors Recommendations made by 
authors 
Gestational diabetes mellitus (GDM) 
Chu, 2007 
(a) 
GDM, adjusted ORs: 
BMI ≥ 30, 3.34 (2.43–4.55) 
BMI ≥ 35, 5.77 (3.60 –9.39) 
 
Numerous studies have reported an increased risk 
of  gestational diabetes mellitus (GDM) among 
women who are overweight or obese compared 
with normal-weight women. 
Prevention strategies, aimed at 
both individual and societal levels. 
Screen women at an early stage for 
preexisting diabetes and to counsel 
women about type 2 diabetes 
prevention in the postpartum 
period. 
Torloni, 
2009 (b) 
GDM, unadjusted OR: 
All BMI ≥ 30, 3.76 
BMI 30- 34.9, 3.01 
BMI ≥ 35, 5.55 
GDM increased 0.92% for every 1 kg m-2 increase 
in women’s BMI 
Changes in maternal intermediary metabolism. 
Insulin receptors and post-receptor defects 
associated with obesity may be further exacerbated 
by pregnancy. A systemic inflammation seems to 
be involved as indicated by higher levels of serum 
C-reactive protein, interleukin-6 and ferritin. As 
adipocytes secrete pro-inflammatory cytokines, 
inflammation is usually associated with obesity. 
Therefore, the abundance of adipocytes in obese 
women could produce excess inflammatory 
markers that in turn would lead to the development 
of GDM. 
Obesity is a possibly modifiable risk 
factor, so obese women should be 
informed about their risks and 
supported to lose weight prior to 
conception. 
 
Pre-eclampsia and hypertension 
Salihu, 
2012 
Narrative synthesis: 
BMI ≥ 30 were 3-10 times more likely to have pre-
eclampsia 
BMI ≥ 30  were 4.5-8.7 times more likely to 
develop gestational hypertension 
Insulin resistance, genetics, immunology, nutrition, 
and infective agents may cause pre-eclampsia, as 
may failure of the trophoblast cells to invade the 
myometrium, oxidative stress, endothelial 
dysfunction, calciotrophic hormone dysfunction, 
release of growth factors, antiagiogenic proteins. 
More research on causative factors 
and development of effective 
preventive interventions.  
Wang, 
2013  
Pre-eclampsia, pooled OR: 
BMI ≥ 30, 2.68 (2.40–3.00) 
BMI ≥ 35, 3.43 (2.59–4.55) 
 
Autonomic function, hyperactivity of the sympathetic 
nervous system may influence blood pressure 
directly, alterations in metabolic functions, including 
insulin resistance, diabetes, dyslipidemia and 
increased blood pressure, oxidative stress and 
chronic inflammation, which can increase the risk of 
pre-eclampsia. 
Further research to determine 
efficacy of antenatal diet or lifestyle 
interventions to prevent pre-
eclampsia and identify the best 
choice for women with high BMI. 
Mode of birth 
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Chu, 2007 
(c) 
Caesarean birth, unadjusted ORs: 
BMI ≥ 30, 2.05 (1.86–2.27) 
BMI ≥ 35, 2.89 (2.28–3.79)  
Increased maternal pelvic soft tissue narrows the 
diameters of the birth canal and increases the risks 
associated with dystocia, a macrosomic infant, or 
cephalopelvic disproportion or differences in labour 
progression or response to oxytocin administration. 
Further research to understand the 
mechanisms between maternal BMI 
and CS.  
 
Heslehurst, 
2008 
Total CS, OR: 
BMI ≥ 30, 2.01 (1.87-2.15); BMI ≥ 35, 1.43 (1.35-
1.52) 
Elective CS: BMI ≥ 30, 1.24 (0.90-1.71) (NS) 
Emergency CS: BMI ≥ 30, 1.63 (1.40-1.89) 
Instrumental vaginal birth: BMI ≥ 30, 1.17 (1.13-
Larger babies may contribute to failure to progress 
in the first or second stages of labour, and may 
require instrumental vaginal births or emergency 
CS.  
 
Developing a successful 
programme of public health 
interventions to prevent maternal 
obesity and clinical guidelines for 
the care of women with high BMI.  
 Poobalan, 
2009 
 
Total CS, unadjusted pooled OR: 
BMI ≥ 30, 2.26 (2.04 - 2.51) 
BMI ≥ 35, 3.38 (2.49-4.57) 
Elective CS, pooled OR: BMI ≥ 30, 1.87 (1.64-
2.12) 
Emergency CS, unadjusted pooled OR: 
BMI ≥ 30, 2.23 (2.07-2.42) 
Possible link between increased cholesterol 
deposits in the myometrium of obese women and 
the increased risk of CS.  
Further research on restricted 
weight gain during pregnancy. 
Surgical site infection (SSI) 
Anderson, 
2013 
 
Synthesis of integrative review:  
12 out of 13 studies supported a relationship 
between obesity and SSI  
Obesity can result in serious post-operative 
complications for child bearing women undergoing 
caesarean section such as SSI. 
Community midwives could 
implement wound assessments 
post-discharge, when SSI is often 
detected. 
Lakhan, 
2010 
Narrative synthesis 
Overall SSI, OR:  
BMI ≥ 30, 2.13 (1.08–4.18) and 2.0 (1.3–3.0) in 
two studies, four studies showed no association. 
 
The lack of consistency in the risk factors studied 
may 
have influenced the risk factors found to be 
independently associated with SSI. 
Future research to test a CS-
specific risk index for surveillance 
purposes, ultimately enhancing 
quality of care for women 
undergoing CS. Mental health 
Molyneaux, 
2014 
Raised depression symptoms, pooled OR: 
BMI ≥ 30, 1.43 (1.27–1.61) 
Elevated depression symptoms, pooled OR:  
BMI ≥ 30, 1.30 (1.20–1.42) 
Antenatal anxiety, pooled OR: 
BMI ≥ 30, 1.41 (1.10–1.80) 
Weight stigmatization, physical ill health, low 
socioeconomic status, and poor diet may contribute 
to effect on mental disorders. Gestational diabetes 
or backache in pregnancy may also increase the 
association. Also, women with a history of 
depression may gain weight before pregnancy, due 
to the obesogenic effect of many antipsychotics or 
antidepressants, or to over-eating. 
Further research on risk of 
gestational diabetes and 
preeclampsia, on behavioral 
change interventions for pregnant 
or postpartum women the effect of 
obesity on women’s health 
behaviors and change in their 
behaviour.  
Pre-term birth  
Heslehurst, 
2008 
PTB (<32 weeks), OR: 
BMI ≥ 30, 1.59 (1.47-1.72) 
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McDonald, 
2010 
PTB (< 37 weeks) Overall risk of PTB in women 
with obesity or normal weight was similar. 
PTB (<33 weeks): Adjusted OR 
BMI 30 to 34.9, 1.49 (0.89-2.50) 
BMI ≥ 34.9 to ≥ 40, 2.02 (1.24-3.29) 
The presence of confounding variables related to obes
and preterm birth might explain some of the results.  
Studies in this review tried to modify this effect by  
exclusion, matching, using multiple regression to  
control for some variables, or by comparing some  
variables between the two groups (obesity and            
normal weight). 
Monitoring PTB should be 
considered in overweight and 
obese women. 
Further research should be done to 
investigate the reason why obese 
women are at risk of PTB and to 
develop better weight loss 
programmes for women of 
childbearing age, before 
Torloni, 
2009 (a) 
Spontaneous PTB, adjusted OR: 
BMI ≥ 30, 0.83 (0.75-0.92) 
PTB 32-36 weeks, adjusted OR: 
BMI ≥ 30, 1.60 (1.32-1.94), BMI ≥ 35, 2.43 (1.46-
4.05) 
PTB in general, adjusted OR: 
BMI ≥ 35, 1.33 (1.12-1.57) 
PTB < 32 weeks, adjusted OR: 
BMI ≥ 40, 2.27 (1.76-2.94)  
Interaction between genetic and environmental 
factors.  
High maternal BMI may have different effects on 
different types of PTB. A short cervix is significantly 
lower among obese compared to normal or 
underweight women and this may in part explain 
their reduced risk for spontaneous PTB. Increased 
nutrient intake may also act as a protective 
mechanism against spontaneous PTB. 
Further research to analyze the 
association between high maternal 
BMI and subtypes of PTB, 
spontaneous PTB, with intact or 
premature rupture of membranes, 
as well as elective PTB. 
Infant birth weight 
Heslehurst, 
2008 
LBW, OR:  
BMI ≥ 30, 0.81 (0.78-0.91), BMI ≥ 35, NS 
HBW, OR: 
BMI ≥ 30, 2.36 (2.29-2.42) 
 
 
National guidelines for clinical 
practice are urgently needed for the 
management of pregnant women 
with BMI ≥ 30. Develop public 
health interventions to prevent 
maternal obesity. 
McDonald, 
2010 
LBW (<2500 g), RR: 
BMI 30 to 34.9, 0.63 (0.34 to 1.19) 
BMI ≥ 34.9 to ≥ 40,  0.81 (0.42 to 1.53) 
The presence of confounding variables related to  
Obesity and low birth weight might explain some of  
the results. Studies in this review tried to modify this 
effect (see above). When authors accounted  for  
publication  bias, b y addition of nine imputed  
studies, the apparent protective effect of obesity  
on low birth weight was no longer seen. 
Health personnel need to be aware 
that obesity in women is not 
necessarily protective against 
having LBW.  
Yu, 2013  LBW (<2,500 g), OR:  
Pre-pregnancy BMI ≥ 30, 0.81 (0.80–0.83) 
LGA (above the 90th percentile) , OR: 
Pre-pregnancy BMI ≥ 30, 2.08 (1.95–2.23) 
HBW (>4,000 g), OR: 
Pre-pregnancy BMI ≥ 30, 2.00 (1.84–2.18) 
Macrosomia (>4,500 g), OR: 
Nutrition in the mother can change the structure, 
physiology, and metabolism in the fetus, 
predisposing that child for high BMI in adulthood. 
Malnutrition or over-nutrition during pregnancy may 
cause epigenetic changes in the fetus/baby, which 
may affect health in adulthood. 
Recognition of the association 
between obesity and birthweight 
has implications for education of 
mothers to reduce pre-pregnancy 
BMI. 
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Pre-pregnancy BMI ≥ 30, 3.23 (2.39–4.37) 
Overweight/obesity in the child, OR: 
Pre-pregnancy BMI ≥ 30, 3.06 (2.68–3.49)  
Fetal defects (malformation) and congenital anomalies 
Stothard, 
2009 
 
 
All malformation risks related to BMI ≥ 30, OR: 
Neural tube defect, 1.87 (1.62-2.15); 
Anencephaly, 1.39 (1.03-1.87); Spina bifida, 2.24 
(1.86-2.69); Cardiovascular anomaly, 1.30 (1.12-
1.51); Septal anomaly, 1.20 (1.09-1.31); Cleft 
palate, 1.23 (1.03-1.47); Cleft lip and palate,  1.20 
(1.03-1.40); Anorectal atresia, 1.48 (1.12-1.97); 
Hydrocephaly, 1.68 (1.19-2.36);  Limb reduction 
anomaly, 1.34 (1.03-1.73); Gastroschisis, 0.17 
(0.10-0.30) 
Undiagnosed diabetes and hyperglycemia in obese 
pregnant women. Nutritional deficiencies, especially 
reduced folate levels (for NTD) and other 
deficiencies for other congenital anomalies. 
Ultrasound scanning more difficult in obese women, 
so maybe fewer terminations for FA. 
Primary prevention strategies for 
offspring overweight/obesity by 
targeting maternal pre-pregnancy 
BMI. Further research powered to 
investigate the complete range of 
BMI to investigate the possible 
pattern of dose response. 
 
Van 
Lieshout, 
2011  
 
 
Narrative review 
Study 1: Unadjusted t-test showed significant 
difference between BMI in mothers of foetal 
alcohol syndrome children (24.9) and control 
mothers (27.5), P = 0.019. 
 
Study 2: Unadjusted ANOVA showed significant 
difference between BMI in mothers of foetal 
alcohol syndrome children (22.5) and control 
mothers (27.4), P = 0.001. 
Case and control mothers differed in a number of 
important ways including socio-economic status, 
education etc. Authors did not control for important 
confounders. 
Strategies designed to reduce pre-
pregnancy obesity and to help 
women reach and maintain healthy 
weights during pregnancy for the 
primary prevention of congenital 
problems. 
Zwink, 
2011  
 
 
Significant association for anorectal anomalies in 
the fetus, OR: 
BMI ≥ 30, 1.64 (1.35-2.00) 
 Need to develop large-scale 
multicentre registers of affected 
infants – basis for more studies 
Fetal death/miscarriage/stillbirth 
Aune, 2014 
 
 
Fetal death, RR: 
BMI ≥ 30, 1.34 (1.22-1.47), BMI ≥ 35, 1.97 (1.71-
2.28), BMI ≥ 40, 3.54 (2.56-4.89) 
Stillbirth, RR: 
BMI ≥ 30, 1.46 (1.37-1.55), BMI ≥ 35, 1.78 (1.67-
1.91), BMI ≥ 40, 2.19 (2.03-2.36) 
 
An underlying biological relationship between 
maternal adiposity and fetal and infant death. High 
BMI is associated with increased risk of 
preeclampsia, gestational diabetes, type 2 diabetes, 
gestational hypertension, and congenital anomalies. 
Decreased possibility to feel fetal movements. 
Placental dysfunction among obese women. 
Weight management guidelines for 
women who plan pregnancies.  
Boots, 
2011 
 
Miscarriage, pooled OR: 
BMI ≥ 28 or BMI ≥ 30, 1.31 (1.18-1.46)  
A possible positive correlation between increasing 
BMI and the risk of miscarriage. 
More studies are urgently needed 
to verify these preliminary results 
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Chu, 2007 
(b) 
 
Stillbirth, OR: 
BMI ≥ 30, 2.07 (1.59-2.74) 
 
Increased risk of GDM and hypertensive disorders, 
both risk factors for stillbirth. Maybe decreased 
possibility to feel fetal movements. More extended 
periods of snoring, more apnea-hypoxia. 
Encourage obese women to 
undertake a weight reduction 
program before attempting 
pregnancy. 
Flenady, 
2011 
 
Stillbirth, adjusted OR: 
BMI ≥ 30, 1.6 (1.35-1.95) 
 
Placental pathology important contributor to stillbirth 
in high-income countries. A substantial proportion of 
stillbirths in such countries lack an obvious maternal 
risk factor and are thought most likely to reflect an 
incompletely understood abnormality of placental 
function, which might or might not be associated 
with impaired growth. 
Weight management before, 
during, and after pregnancy. 
Awareness of the risks associated 
with common pre-gestational and 
gestational medical disorders. 
Miscellaneous outcomes  
Heslehurst, 
2008 
Neonatal intensive care use, OR: 
BMI ≥ 30, 1.38 (1.16-1.64), BMI ≥ 35, 1.33 (1.18-
1.51) 
Fetal compromise, OR: 
BMI ≥ 30, 1.62 (1.54-1.70), BMI ≥ 35, 2.08 (1.92-
2.25) 
Meconium, OR:  BMI ≥ 30, 1.57 (1.42-1.73) 
Postpartum hemorrhage, OR: 
BMI ≥ 30, 1.20 (1.16-1.24), BMI ≥ 35, 1.43 (1.33-
1.54) 
Placenta previa, OR:  BMI ≥ 30, 0.83 (0.71-0.96) 
Shoulder dystocia, OR:  BMI ≥ 30, 1.04 (0.97-
1.12), NS 
Third and fourth degree tears, NS 
Length of hospital stay (mean days), OR: 
BMI ≥ 30, 2.71 (2.62-2.79),  BMI ≥ 35, 3.28 (3.13-
3.43) 
Postdate birth (>41/42 weeks), OR: 
BMI ≥ 30, 1.37 (1.33-1.41), BMI ≥ 35, 1.56 (1.48-
1.64) 
Induction of labour, OR: BMI ≥ 30, 1.88 (1.84-
1.92) 
Oxytocin augmentation, OR: BMI ≥ 30, 1.59 (1.36-
1.87) 
Failure to progress, OR: BMI ≥ 30, 2.31 (1.87-
2.82) 
Larger babies may contribute to failure to progress 
in the first or second stages of labour, and may 
require instrumental vaginal births or emergency 
CS.  
 
Developing a successful 
programme of public health 
interventions to prevent maternal 
obesity and clinical guidelines for 
the care of women with high BMI. 
 
Breast feeding  
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Amir, 2007 Women with BMI ≥ 30, compared with normal 
weight women 
Not commencing breast feeding, range of ORs: 
1.38 to 3.09 
 
Seven out of 15 studies found that women with 
obesity 
breastfed for a shorter duration than did women 
with normal weight 
Obesity is associated with delayed lactogenesis. As 
this review also showed that women with obesity 
intend to breastfeed for shorter durations than other 
women, perhaps part of the delay in time to first 
feed and tendency to give up before hospital 
discharge is behavioural rather than physiological. 
Qualitative studies from women's 
perspective as well as quantitative 
studies are necessary, to explore 
the relationship between maternal 
obesity and breastfeeding. 
Turcksin, 
2012 
Women with BMI ≥ 30, compared with normal 
weight women 
Initiating of breastfeeding, range of ORs (10 
studies): 
1.19 to 3.65 
Low milk transfer at 60 hrs, range of ORs:  
6.14 (1.10-37.41) 
Early cessation of breastfeeding, range of hazard 
ratios:1.24 to 2.54 
 
Maternal obesity is associated with a decreased 
intention and initiation of breastfeeding, a shortened 
duration of breastfeeding, a less adequate milk 
supply and a delayed onset of lactogenesis. Larger 
breasts can be a mechanical barrier to put the baby 
to the breast, and can therefore have a negative 
influence on the milk production and secretion. 
 
Additional education for health care 
professionals. Breastfeeding 
promotion interventions and 
counselling practices targeting 
women with BMI ≥ 30, and 
assistance for breastfeeding, 
starting before conception until 6 
months post-partum. 
CS= caesarean section, SSI=surgical site infection, PTB=preterm birth, LBW=low birth weight, HBW=high birth weight, LGA=large for gestational age, 
OR=odds ratio (95% confidence interval), RR=relative risk, HR=hazard ratio 
* Four studies found NS results  
 
